Treace Medical Concepts, Inc. Common Stock

TMCINASDAQ • USD
5.27 USD
↘ 0.07 (1.31%)AT CLOSE (03:59 PM EST)
5.27
↗ 0.01 (0.09%)
POST MARKET (AS OF 04:14 PM EST)
Post Market
AS OF 04:14 PM EST
5.27
↗ 0.01 (0.09%)
🔴Market: CLOSED

TMCI is currently priced at $5.27. Technicals currently rate "Strong Buy" while our fundamental analysis reads "Neutral". Key drivers include a concerning Altman Z-Score in the distress zone, negative Return on Equity, a bullish Golden Cross on the moving averages and bullish moving average alignment. On the valuation side, TMCI appears attractively valued relative to sector peers across key multiples.

Technical & fundamental data as of Nov 13, 2026.

Open?$5.32
High?$5.32
Low?$4.95
Prev. Close?$5.34
Volume?287.8K
Avg. Volume?298.6K
VWAP?$5.17
Rel. Volume?0.96x
Bid / Ask
Bid?$3.26 × 100
Ask?$5.40 × 200
Spread?$2.14
Midpoint?$4.33
Valuation & Ratios
Market Cap?345.5M
Shares Out?65.0M
Float?47.5M
Float %?73.1%
P/E Ratio?N/A
P/B Ratio?5.60
EPS?-$0.85
Dividend?0.00%
Ex-Dividend?N/A
News
Profile
Treace Medical Concepts Inc is a commercial-stage orthopaedic medical device company. It is focused on advancing the standard of care for the surgical management of bunion deformities. The company's patented Lapiplasty 3D Bunion Correction procedure is designed to reproducibly correct all planes of the bunion deformity and address the root cause of the bunion, while allowing patients to return to their active lives quickly. The company operates and manages its business as a single segment: designing, manufacturing, and marketing medical devices for surgeons, ambulatory surgery centers, and hospitals related to the surgical management of bunion and related midfoot deformities.
Employees
450
Market Cap
350.1M
Industry
SURGICAL & MEDICAL INSTRUMENTS & APPARATUS
Listed
2021-04-23
Address
100 PALMETTO PARK PLACE
PONTE VEDRA, FL 32081
Phone: (904) 373-5940
Technical OutlookStrong Buy
Strong SellNeutralStrong Buy
Long-Term (Tide)?▲ Bullish(+3/3)
Medium-Term (Wave)?▲ Bullish(+2/3)
Short-Term (Ripple)?▲ Bullish(+2/3)
MA Alignment?Golden Alignment
Full Technical Analysis →
Fundamental OutlookNeutral
Strong SellNeutralStrong Buy
F-Score?
23
Z-Score?
4
Momentum?
77
Short Sent.?
68
Piotroski F-Score?3/9Weak
Altman Z-Score?0.19Distress
Confidence?54%Low
Full Fundamental Analysis →
Short InterestHigh
Short % of Float?3.77%Low
Short Interest?1.8M
Days to Cover?8.7
Free Float47.5M
Avg Daily Volume207.0K
Settlement Date2026-10-30
Financial Health
Current Ratio?2.58Strong
Quick Ratio?1.66Adequate
Cash Ratio?0.17Low
Debt/Equity?0.91Moderate
ValuationATTRACTIVELY VALUEDvs 1 peers + S&P 500
Score
92/100
P/E?
N/A▾
P/B?
Peers
100
S&P
33
5.60FAIR▾
P/S?
Peers
100
S&P
74
1.70CHEAP▾
P/FCF?
N/A▾
EV/EBITDA?
S&P
97
-9.5CHEAP▾
EV/Sales?
Peers
100
S&P
76
1.94CHEAP▾
Returns & Efficiency
ROE?
S&P
3
-90.6%WEAK▾
ROA?
S&P
3
-31.2%WEAK▾
Cash Flow & Enterprise
FCF?$-18571000
Enterprise Value?$394.0M
Fundamentals ratios updated end of day